Thomasville National Bank’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.69M Buy
+26,575
New +$5.72M 0.37% 47
2025
Q4
$6.32M Buy
27,675
+217
+0.8% +$49.4K 0.39% 46
2025
Q3
$6.36M Sell
27,458
-60
-0.2% -$12.2K 0.4% 45
2025
Q2
$5.11M Sell
27,518
-2,562
-9% -$476K 0.35% 48
2025
Q1
$6.3M Buy
30,080
+168
+0.6% +$32.7K 0.46% 46
2024
Q4
$5.32M Sell
29,912
-230
-0.8% -$42.3K 0.38% 48
2024
Q3
$5.95M Sell
30,142
-776
-3% -$145K 0.44% 45
2024
Q2
$5.3M Sell
30,918
-155
-0.5% -$25.7K 0.42% 46
2024
Q1
$5.66M Sell
31,073
-202
-0.6% -$34.8K 0.47% 44
2023
Q4
$4.85M Sell
31,275
-860
-3% -$125K 0.43% 45
2023
Q3
$4.79M Buy
32,135
+161
+0.5% +$23.6K 0.47% 44
2023
Q2
$4.31M Sell
31,974
-163
-0.5% -$23.9K 0.41% 46
2023
Q1
$5.12M Sell
32,137
-495
-2% -$75.7K 0.53% 45
2022
Q4
$5.27M Sell
32,632
-153
-0.5% -$23.5K 0.61% 41
2022
Q3
$4.4M Sell
32,785
-1,943
-6% -$279K 0.53% 45
2022
Q2
$5.32M Sell
34,728
-18,756
-35% -$2.87M 0.59% 45
2022
Q1
$8.67M Sell
53,484
-114,540
-68% -$16.6M 0.84% 32
2021
Q4
$22.8M Buy
168,024
+171
+0.1% +$20.2K 2.18% 15
2021
Q3
$18.1M Buy
167,853
+1,133
+0.7% +$129K 1.88% 19
2021
Q2
$18.8M Sell
166,720
-5,252
-3% -$592K 1.99% 16
2021
Q1
$13.1M Buy
171,972
+10,903
+7% +$1.17M 2.44% 12
2020
Q4
$17.3M Sell
161,069
-347
-0.2% -$33.3K 2.27% 16
2020
Q3
$14.1M Sell
161,416
-7,443
-4% -$701K 2.13% 19
2020
Q2
$16.6M Sell
168,859
-161
-0.1% -$14.2K 2.57% 10
2020
Q1
$12.8M Sell
169,020
-511
-0.3% -$43.5K 2.13% 17
2019
Q4
$15M Buy
169,531
+511
+0.3% +$42.4K 2.32% 14
2019
Q3
$12.8M Buy
169,020
+124,007
+275% +$8.5M 2.13% 17
2019
Q2
$3.27M Buy
45,013
+1,118
+3% +$87.9K 0.57% 45
2019
Q1
$3.54M Buy
43,895
+1,938
+5% +$159K 0.65% 38
2018
Q4
$3.87M Sell
41,957
-1,591
-4% -$140K 0.79% 36
2018
Q3
$4.12M Buy
43,548
+167
+0.4% +$15.8K 0.66% 37
2018
Q2
$4.02M Sell
43,381
-2,027
-4% -$198K 0.69% 36
2018
Q1
$4.3M Buy
45,408
+5,450
+14% +$599K 0.76% 34
2017
Q4
$3.86M Sell
39,958
-12,613
-24% -$1.19M 0.72% 38
2017
Q3
$4.67M Buy
52,571
+184
+0.4% +$14K 0.77% 38
2017
Q2
$3.8M Buy
52,387
+1,506
+3% +$101K 0.69% 40
2017
Q1
$3.31M Buy
+50,881
New +$3.2M 0.66% 42
2016
Q3
$2.61M Buy
41,316
+11,870
+40% +$768K 1.52% 19
2016
Q2
$1.82M Buy
29,446
+993
+3% +$60.5K 0.48% 53
2016
Q1
$1.63M Buy
28,453
+8,263
+41% +$461K 0.49% 50
2015
Q4
$1.2M Sell
20,190
-11,387
-36% -$656K 0.42% 48
2015
Q3
$1.72M Sell
31,577
-774
-2% -$50.4K 0.63% 44
2015
Q2
$2.17M Buy
32,351
+899
+3% +$58.7K 0.75% 43
2015
Q1
$1.84M Sell
31,452
-3,768
-11% -$228K 0.63% 43
2014
Q4
$2.31M Sell
35,220
-1,371
-4% -$86.4K 0.82% 39
2014
Q3
$2.11M Sell
36,591
-1,465
-4% -$81.3K 0.81% 37
2014
Q2
$2.15M Sell
38,056
-17,746
-32% -$931K 0.78% 39
2014
Q1
$2.87M Buy
55,802
+661
+1% +$33.4K 1.18% 34
2013
Q4
$2.91M Buy
55,141
+16,070
+41% +$790K 1.28% 33
2013
Q3
$1.75M Sell
39,071
-2,539
-6% -$113K 0.91% 34
2013
Q2
$1.72M Buy
+41,610
New +$1.82M 1.13% 30

Other funds holding ABBV

Thomasville National Bank's ABBV Position: Q2 2026 in Review

Thomasville National Bank opened a new position in AbbVie (ABBV) in Q2 2026: 26,575 shares worth $6.69M. The stake represents 0.37% of the portfolio and ranks #47 among its holdings. This is a return to the name: Thomasville National Bank previously reported a position in ABBV as recently as Q4 2025.

Thomasville National Bank first reported a position in ABBV in Q2 2013 and has held it in 51 quarters since. The position peaked at $22.8M in Q4 2021. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Thomasville National Bank held 26,575 shares of AbbVie worth $6.69M as of Q2 2026.
  • AbbVie was a new Thomasville National Bank position in Q2 2026.
  • AbbVie made up 0.37% of Thomasville National Bank's portfolio in Q2 2026, its #47 holding.
  • Thomasville National Bank first reported a position in AbbVie in Q2 2013 and has held it in 51 quarters since.
  • Thomasville National Bank's AbbVie position peaked at $22.8M in Q4 2021.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Thomasville National Bank's 13F filing for Q2 2026, filed 20 Jul 2026.